---
title: "Changes in Senior Management at Chongqing Iron and Steel"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281115785.md"
description: "Chongqing Iron announced that the board of directors has reviewed and approved the \"Proposal on Changes in Senior Management,\" authorizing Senior Vice President Zhao Shiqing to act as the President, effective from the date of this board meeting until the appointment of the President by the board. Li Haifeng has been appointed as Senior Vice President, with a term starting from the date of this board meeting until the end of the current board's term"
datetime: "2026-03-31T02:57:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281115785.md)
  - [en](https://longbridge.com/en/news/281115785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281115785.md)
---

# Changes in Senior Management at Chongqing Iron and Steel

Chongqing Iron (01053.HK) announced that the board of directors has reviewed and approved the "Proposal on Changes in Senior Management," authorizing Senior Vice President Zhao Shiqing to act as the President, effective from the date of this board meeting until the appointment of a new President by the board. Li Haifeng has been appointed as Senior Vice President, with a term effective from the date of this board meeting until the end of the current board's term

### Related Stocks

- [601005.CN](https://longbridge.com/en/quote/601005.CN.md)
- [01053.HK](https://longbridge.com/en/quote/01053.HK.md)
- [515210.CN](https://longbridge.com/en/quote/515210.CN.md)

## Related News & Research

- [Chongqing Iron & Steel Shareholders Approve All Resolutions, Whitewash Waiver Granted](https://longbridge.com/en/news/279062450.md)
- [Chongqing Iron & Steel Updates Investors on Delayed Circular for A-Share Issuance and Whitewash Waiver](https://longbridge.com/en/news/275310588.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [JPMorgan lowers 2026 gold forecast, still sees rally towards $6,000 on renewed demand](https://longbridge.com/en/news/286715908.md)